Wednesday, November 18, 2026
FDA RECALLClass IINovember 10, 2026

FDA Class II: Victory Medical Center Pharmacy Recalls THYMOSIN ALPHA-1 (MDV) 3MG/ML **5ML**, VMC, Victory Medical Center Pharmacy, Aus

Affected Product:THYMOSIN ALPHA-1 (MDV) 3MG/ML **5ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
Recalling Firm / Manufacturer:Victory Medical Center Pharmacy
Reference / Recall Number:D-0145-2027
Distribution Scope:CO, FL, TX
Executive Summary:

Class II announced by FDA for THYMOSIN ALPHA-1 (MDV) 3MG/ML **5ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas. Reason: Lack of Processing Controls...

The U.S. Food and Drug Administration (FDA) has posted an official drug enforcement report concerning Victory Medical Center Pharmacy.

Product and Classification Details

  • Recall Number: D-0145-2027
  • Classification: Class II
  • Recalling Firm: Victory Medical Center Pharmacy
  • Status: Ongoing

Reason for Enforcement Action

Lack of Processing Controls

Distribution Information

CO, FL, TX

Official notification published per FDA Center for Drug Evaluation and Research (CDER) surveillance databases.
Official Regulatory Docket:Open Agency Docket